Brazilian Society of Hepatology and Brazilian College of Radiology practice guidance for the use of elastography in liver diseases

• Published in: Annals of hepatology 2021-05, Vol.22, p.100341-100341, Article 100341
• Main Authors: Cardoso, Ana Carolina, A. Villela-Nogueira, Cristiane, de Figueiredo-Mendes, Cláudio, Leão Filho, Hilton, Pinto Silva, Rogério Augusto, Valle Tovo, Cristiane, Perazzo, Hugo, Matteoni, Antonio Carlos, de Carvalho-Filho, Roberto José, Lisboa Bittencourt, Paulo
• Format: Article
• Language: English
• Subjects: Chronic liver diseases liver biopsy; Elastography; Fibrosis; Non-invasive tools
• ISSN: 1665-2681; 2659-5982
• DOI: 10.1016/j.aohep.2021.100341

In 2015 the European Association for the Study of Liver Diseases (EASL) and the Asociación Latinoamericana para el Estudio del Hígado (ALEH) published a guideline for the use of non-invasive markers of liver disease. At that time, this guideline focused on the available data regarding ultrasonic-related elastography methods. Since then, much has been published, including new data about XL probe use in transient elastography, magnetic resonance elastography, and non-invasive liver steatosis evaluation. In order to draw evidence-based guidance concerning the use of elastography for non-invasive assessment of fibrosis and steatosis in different chronic liver diseases, the Brazilian Society of Hepatology (SBH) and the Brazilian College of Radiology (CBR) sponsored a single-topic meeting on October 4th, 2019, at São Paulo, Brazil. The aim was to establish specific recommendations regarding the use of imaging-related non-invasive technology to diagnose liver fibrosis and steatosis based on the discussion of evidence-based topics by an organizing committee of experts. It was submitted online to all SBH and CBR members. The present document is the final version of the manuscript that supports the use of this new technology as an alternative to liver biopsy.